Skip to main content
. 2019 Feb 13;79(4):365–379. doi: 10.1007/s40265-019-1064-1

Fig. 1.

Fig. 1

Pathogenesis and management flow-chart of hypertension in chronic kidney disease. ACEi angiotensin converting enzyme inhibitor, ARB angiotensin II receptor antagonist (blocker), CCB calcium channel antagonist (blocker), CKD chronic kidney disease, RAAS renin–angiotensin–aldosterone system